NIH Launches Study to Evaluate Three mRNA Vaccines for HIV
NIAID has launched a Phase I clinical trial evaluating three experimental HIV vaccines based on a mRNA platform — a technology used in several approved COVID-19 vaccines.
Intranasal Flu Vaccine Developed with Nanoparticles
Researchers in a study funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health have developed an influenza (flu) vaccine administered through the nose that has been constructed with nanoparticles and offers stronger protection.
Vaccine Passports: Vaccination Confirmation or a Privacy Concern?
The implementation of vaccine passports in response to the COVID-19 pandemic has raised arguments for and against them.
Scientists Are Developing Cheaper, Patent-Free and Easier-to-Make COVID Vaccine
Researchers at the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine are developing a COVID-19 vaccine using a conventional method that will make the production and distribution cheaper and more accessible.
Immunity Debt: A Catalyst for the Development of Infections and Autoimmune Disease?
Are precautions to stop the spread of COVID-19 now causing other widespread illness?
The Promise of mRNA Vaccines for Disease Prevention
Using mRNA technology, the same science that developed mRNA COVID-19 vaccines, Pfizer and Moderna are testing multiple vaccines to prevent diseases that cause millions of deaths each year.
Experimental Vaccine Developed to Prevent Rheumatoid Arthritis
Researchers at the University of Toledo have developed an experimental vaccine to prevent rheumatoid arthritis, one of the most common autoimmune disorders
CMS Launches New Medicare.gov Tool to Compare Nursing Home Vaccination Rates
The Centers for Medicare & Medicaid Services (CMS) is making it easier to check COVID-19 vaccination rates for nursing home staff and residents by making vaccination data available in a user-friendly format.
OCR Issues Guidance on HIPAA, COVID-19 Vaccinations and the Workplace
The U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) issued guidance to help the public understand when the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule applies to disclosures and requests for information about whether a person has received a COVID-19 vaccine.
Universal Flu Vaccines Advance from Concept to Clinical Trials
“Scientists have identified components of the influenza virus that do not really change muchat all. The critical challenge is getting a vaccine to induce a response to those components.”
— Anthony Fauci, MD, Director, National Institute of Allergy and Infectious Diseases